Valuation: Medico Remedies Limited

Market Cap 2.71B 28.46M 24.62M 22.99M 21.09M 39.67M 40.3M 270M 106M 1.36B 107M 105M 4.49B P/E 2024
49.3x
P/E 2025 42.8x
Enterprise Value 2.83B 29.74M 25.72M 24.02M 22.04M 41.45M 42.1M 282M 111M 1.42B 112M 109M 4.69B EV / Sales 2024
2.87x
EV / Sales 2025 2.94x
Free-Float
30.55%
Yield 2024 *
-
Yield 2025 -
1 day-0.64%
1 week-7.00%
Current month-3.85%
1 month+17.36%
3 months+14.56%
6 months-6.23%
Current year-8.03%
1 week 44.65
Extreme 44.65
49.53
1 month 37.01
Extreme 37.01
52.85
Current year 31
Extreme 31
56.99
1 year 31
Extreme 31
56.99
3 years 31
Extreme 31
92.87
5 years 9.98
Extreme 9.975
100.79
10 years 3.35
Extreme 3.35
100.79
Manager TitleAgeSince
Chief Executive Officer 40 2017-09-14
Director of Finance/CFO 71 2017-09-14
Compliance Officer - 2026-02-17
Director TitleAgeSince
Chairman 71 1994-03-17
Director/Board Member 40 2011-12-13
Director/Board Member 65 2017-09-14
Date Insider Type Main position Quantity % Market Cap.
12/5/24 Sell

Director

1,400,000 1.6871%
12/5/24 Sell

Director

400,000 0.4820%
11/20/24 Sell

General Counsel

900,000 1.0845%
Change 5-day change 1-year change 3-year change Capi.($)
-0.64%-7.00%+19.66%-40.18% 40.81M
-0.52%+3.21%+89.52%+125.32% 1,057B
+0.88%+1.13%+49.56%+49.79% 625B
+0.89%-1.95%+24.23%+63.19% 435B
+0.71%+3.87%+49.07%+38.29% 363B
+0.64%-0.49%+33.94%+38.94% 296B
+0.39%-5.83%+8.92%+6.39% 249B
+1.51%+6.69%+42.58%+58.47% 222B
+3.92%-0.46%-5.56%-51.70% 209B
+1.80%+2.30%+11.56%+66.16% 165B
Average +0.96%+0.52%+32.35%+35.47% 362.08B
Weighted average by Cap. +0.66%+1.33%+48.72%+63.85%

Financials

2024 2025
Net sales 1.45B 15.23M 13.17M 12.3M 11.28M 21.22M 21.56M 144M 56.64M 726M 57.18M 55.93M 2.4B 1.51B 15.86M 13.72M 12.81M 11.75M 22.1M 22.46M 150M 59M 757M 59.56M 58.25M 2.5B
Net income 82.91M 871K 754K 704K 646K 1.21M 1.23M 8.26M 3.24M 41.56M 3.27M 3.2M 137M 101M 1.06M 917K 857K 786K 1.48M 1.5M 10.05M 3.94M 50.59M 3.98M 3.9M 167M
Net Debt 65.05M 683K 591K 552K 506K 953K 968K 6.48M 2.54M 32.6M 2.57M 2.51M 108M 122M 1.28M 1.1M 1.03M 946K 1.78M 1.81M 12.1M 4.75M 60.92M 4.8M 4.69M 201M
Logo Medico Remedies Limited
Medico Remedies Limited is an India-based company, principally engaged in the pharmaceutical business. The Company is involved in the development, manufacture and sale of pharmaceutical and nutraceutical products. It focuses on anti-infective, Beta-Lactams, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, hematinic and other supplements. The Company also manufactures and markets capabilities in other drugs such as non-steroidal anti-inflammatory drugs (NSAIDS), antihistaminic, anti-diabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream and gel for various therapeutic segments. Its products include Doxycycline Capsules, Zenof-400 (Ofloxacin Tablets 400mg), Azithromycin Tablets, Aciclovir Tablets, Cipta Tablets, Cotrimoxazole Tablets, Tos Syrup, Pediatric Co-Trimozole Oral, Med Reactin (Cyproheptadine), and Medivit Syrup, among others. Its syrups include Medivit Syrup and Ferrovit Syrup.
Employees
213
Date Price Change Volume
26-08-10 46.50 -0.64% 1,664
26-08-07 ₹46.80 -1.43% 5,449
26-08-06 ₹47.48 -1.86% 14,610
26-08-05 ₹48.38 -0.98% 9,594
26-08-04 ₹48.86 -2.28% 27,603
  1. Stock Market
  2. Stocks
  3. MEDICO Stock